Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies

British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

(2009) C.H. Smith et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatments for psoriasis and the risk of malignancy

(2009) Rita V. Patel et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

(2009) Kenneth R Carson et al.   LANCET ONCOLOGY

European biologicals registers: methodology, selected results and perspectives

(2008) A Zink et al.   ANNALS OF THE RHEUMATIC DISEASES

National Registries of Systemic Treatment for Psoriasis and the European ‘Psonet’ Initiative

(2008) L.L.A. Lecluse et al.   DERMATOLOGY

Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION